REMOVAL OF NEUROBLASTOMA CELLS FROM BONE MARROW WITH MONOCLONAL ANTIBODIES CONJUGATED TO MAGNETIC MICROSPHERES
- 1 January 1984
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 323 (8368) , 70-73
- https://doi.org/10.1016/s0140-6736(84)90004-7
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Monodisperse polymer particles — a step forward for chromatographyNature, 1983
- Monoclonal antibody UJ 127:11 detects a 220,000‐240,000 kdal. Glycoprotein present on a sub‐set of neuroectodermally derived cellsInternational Journal of Cancer, 1983
- USE OF PANELS OF MONOCLONAL ANTIBODIES IN THE DIFFERENTIAL DIAGNOSIS OF NEUROBLASTOMA AND LYMPHOBLASTIC DISORDERSThe Lancet, 1983
- 4‐Hydroperoxyclophosphamide: a model for eliminating residual human tumour cells and T‐lymphocytes from the bone marrow graftBritish Journal of Haematology, 1982
- AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CALLA-POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA AFTER IN-VITRO TREATMENT WITH J5 MONOCLONAL ANTIBODY AND COMPLEMENTThe Lancet, 1982
- Selective killing of malignant cells in a leukaemic rat bone marrow using an antibody–ricin conjugateNature, 1982
- Selective killing of leukaemia cells by antibody–toxin conjugates: implications for autologous bone marrow transplantationNature, 1982
- Swelling of oligomer-polymer particles. New methods of preparationAdvances in Colloid and Interface Science, 1980
- Derivation of specific antibody‐producing tissue culture and tumor lines by cell fusionEuropean Journal of Immunology, 1976
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975